BSE filing, NSE: ORIENTCEM. Summary written from the filing by ALFA Finder's alert engine.
Orient Cement Ltd: key numbers
- Share price
- ₹113.20
- Market cap
- ₹2,326 Cr
- Revenue (annual)
- ₹2,793 Cr
- Net profit (annual)
- ₹337.7 Cr
- P/E (TTM)
- 12.1×Sector 31.7×
- Promoter holding
- 72.66%+0.00% QoQ
- FII holding
- 3.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orient Cement Ltd
All →Orient Cement Share Pledge
Deutsche Bank reported an encumbrance over 72.66% of Orient Cement shares, extended to a new Endeavour facility. No shares changed hands and no value is stated.
Orient Cement Q2 FY27 Results: Net Profit ₹32 Cr, Down 34.7% YoY
Orient Cement Ltd reported revenue from operations of ₹565 Cr (-12.1% YoY) and net profit of ₹32 Cr (-34.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹32 Cr · -34.7% YoY
Orient Cement Board Meeting Date
Orient Cement Limited has scheduled a board meeting for October 22, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Orient Cement Acquisition
Orient Cement's equity shareholders approved the Scheme of Amalgamation with Ambuja Cements Limited at the NCLT-convened meeting held on September 28, 2026.
Orient Cement Management Change
Orient Cement Limited announced the resignation of Ms. Kajal Saxena as Chief Financial Officer, effective September 18, 2026.
Orient Cement Acquisition
Orient Cement Limited announced a court-convened meeting on September 28, 2026, to seek shareholder approval for its scheme of amalgamation with Ambuja Cements Limited.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.